Corporate Growth Strategy (continued)
Build our market share in devices such as multi-component, multi-material systems (Market: $4.5 BN)
Leverage our customer base
- Develop a portfolio of proprietary systems for injectable, transmucosal, and pulmonary delivery
- Pursue selected consumer opportunities that satisfy our selection criteria
- License or acquire innovative technologies
- Consider strategic acquisitions